A multi-center, open-label, two-part study to investigate the effect of renal function and hemodialysis on the pharmacokinetics of the novel beta-lactamase inhibitor nacubactam. (journals.asm.org)

Authors: Morita J … Bentley D Journal: Antimicrobial Agents and Chemotherapy Published: 2026-06-03 DOI: https://doi.org/10.1128/aac.00113-26